Canada markets closed

Novartis AG (NVSEF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
96.00-0.87 (-0.90%)
At close: 03:43PM EST

Novartis AG

Lichtstrasse 35
Basel 4056
41 61 324 1111

IndustryDrug Manufacturers - General
Full Time Employees101,703

Key Executives

NameTitlePayExercisedYear Born
Dr. Vasant NarasimhanChief Executive Officer5.85MN/A1976
Mr. Harry KirschChief Financial Officer2.96MN/A1965
Dr. Steffen Lang Ph.D.President of Operations2.43MN/A1967
Dr. Klaus Moosmayer Ph.D.Chief Ethics, Risk & Compliance Officer1.61MN/A1968
Ms. Karen L. HaleChief Legal Officer2.44MN/A1968
Dr. Robert Kowalski Pharm.D.Chief People & Organization Officer2.18MN/A1968
Mr. Victor BultoPresident of US2.39MN/AN/A
Dr. Shreeram Aradhye M.D.President of Global Drug Development & Chief Medical Officer2.38MN/A1963
Mr. Aharon Gal Ph.D.Chief Strategy & Growth Officer6.54MN/AN/A
Dr. Fiona H. Marshall Ph.D.President of BioMedical Research5.3MN/A1964
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland.

Corporate Governance

Novartis AG’s ISS Governance QualityScore as of December 1, 2023 is 1. The pillar scores are Audit: 1; Board: 2; Shareholder Rights: 1; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.